240 related articles for article (PubMed ID: 31054643)
1. Detection of familial hypercholesterolaemia: external validation of the FAMCAT clinical case-finding algorithm to identify patients in primary care.
Weng S; Kai J; Akyea R; Qureshi N
Lancet Public Health; 2019 May; 4(5):e256-e264. PubMed ID: 31054643
[TBL] [Abstract][Full Text] [Related]
2. Evaluating a clinical tool (FAMCAT) for identifying familial hypercholesterolaemia in primary care: a retrospective cohort study.
Akyea RK; Qureshi N; Kai J; de Lusignan S; Sherlock J; McGee C; Weng S
BJGP Open; 2020 Dec; 4(5):. PubMed ID: 33144363
[TBL] [Abstract][Full Text] [Related]
3. Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care.
Qureshi N; Akyea RK; Dutton B; Leonardi-Bee J; Humphries SE; Weng S; Kai J
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34635577
[TBL] [Abstract][Full Text] [Related]
4. Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT).
Weng SF; Kai J; Andrew Neil H; Humphries SE; Qureshi N
Atherosclerosis; 2015 Feb; 238(2):336-43. PubMed ID: 25555265
[TBL] [Abstract][Full Text] [Related]
5. High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study.
Langsted A; Kamstrup PR; Benn M; Tybjærg-Hansen A; Nordestgaard BG
Lancet Diabetes Endocrinol; 2016 Jul; 4(7):577-87. PubMed ID: 27185354
[TBL] [Abstract][Full Text] [Related]
6. Electronic health record-based facilitation of familial hypercholesterolaemia detection sensitivity of different algorithms in genetically confirmed patients.
Mohammadnia N; Akyea RK; Qureshi N; Bax WA; Cornel JH
Eur Heart J Digit Health; 2022 Dec; 3(4):578-586. PubMed ID: 36710904
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of various familial hypercholesterolaemia diagnostic criteria compared to Dutch lipid clinic criteria in an Asian population.
Abdul-Razak S; Rahmat R; Mohd Kasim A; Rahman TA; Muid S; Nasir NM; Ibrahim Z; Kasim S; Ismail Z; Abdul Ghani R; Sanusi AR; Rosman A; Nawawi H
BMC Cardiovasc Disord; 2017 Oct; 17(1):264. PubMed ID: 29037163
[TBL] [Abstract][Full Text] [Related]
8. Reducing Premature Coronary Artery Disease in Malaysia by Early Identification of Familial Hypercholesterolemia Using the Familial Hypercholesterolemia Case Ascertainment Tool (FAMCAT): Protocol for a Mixed Methods Evaluation Study.
Ramli AS; Qureshi N; Abdul-Hamid H; Kamal A; Kanchau JD; Shahuri NS; Akyea RK; Silva L; Condon L; Abdul-Razak S; Al-Khateeb A; Chua YA; Mohamed-Yassin MS; Baharudin N; Badlishah-Sham SF; Abdul Aziz AF; Mohd Kasim NA; Sheikh Abdul Kadir SH; Kai J; Leonardi-Bee J; Nawawi H
JMIR Res Protoc; 2023 Jun; 12():e47911. PubMed ID: 37137823
[TBL] [Abstract][Full Text] [Related]
9. Clinical and genetic diagnosis of familial hypercholesterolaemia in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study.
Molnar S; Scharnagl H; Delgado GE; Krämer BK; Laufs U; März W; Kleber ME; Katzmann JL
Eur Heart J Qual Care Clin Outcomes; 2024 Jan; ():. PubMed ID: 38196142
[TBL] [Abstract][Full Text] [Related]
10. Strategies for screening for familial hypercholesterolaemia in primary care and other community settings.
Qureshi N; Da Silva MLR; Abdul-Hamid H; Weng SF; Kai J; Leonardi-Bee J
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD012985. PubMed ID: 34617591
[TBL] [Abstract][Full Text] [Related]
11. Precision screening for familial hypercholesterolaemia: a machine learning study applied to electronic health encounter data.
Myers KD; Knowles JW; Staszak D; Shapiro MD; Howard W; Yadava M; Zuzick D; Williamson L; Shah NH; Banda JM; Leader J; Cromwell WC; Trautman E; Murray MF; Baum SJ; Myers S; Gidding SS; Wilemon K; Rader DJ
Lancet Digit Health; 2019 Dec; 1(8):e393-e402. PubMed ID: 33323221
[TBL] [Abstract][Full Text] [Related]
12. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
[TBL] [Abstract][Full Text] [Related]
13. A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice.
Troeung L; Arnold-Reed D; Chan She Ping-Delfos W; Watts GF; Pang J; Lugonja M; Bulsara M; Mortley D; James M; Brett T
Heart; 2016 Jun; 102(11):855-61. PubMed ID: 26864669
[TBL] [Abstract][Full Text] [Related]
14. US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.
Ahmad ZS; Andersen RL; Andersen LH; O'Brien EC; Kindt I; Shrader P; Vasandani C; Newman CB; deGoma EM; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Kullo IJ; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
J Clin Lipidol; 2016; 10(5):1223-9. PubMed ID: 27678440
[TBL] [Abstract][Full Text] [Related]
15. Introducing genetic testing with case finding for familial hypercholesterolaemia in primary care: qualitative study of patient and health professional experience.
Silva L; Condon L; Qureshi N; Dutton B; Weng S; Kai J
Br J Gen Pract; 2022 Jul; 72(720):e519-e527. PubMed ID: 35697509
[TBL] [Abstract][Full Text] [Related]
16. The genetics and screening of familial hypercholesterolaemia.
Henderson R; O'Kane M; McGilligan V; Watterson S
J Biomed Sci; 2016 Apr; 23():39. PubMed ID: 27084339
[TBL] [Abstract][Full Text] [Related]
17. Application of a risk stratification tool for familial hypercholesterolaemia in primary care: an observational cross-sectional study in an unselected urban population.
Carvalho C; Williams C; Raisi-Estabragh Z; Rison S; Patel RS; Timmis A; Robson J
Heart; 2021 Jul; 107(15):1220-1225. PubMed ID: 34016698
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Screening Algorithms for Familial Hypercholesterolaemia in Primary Care.
Jones M; Akyea RK; Payne K; Humphries SE; Abdul-Hamid H; Weng S; Qureshi N
J Pers Med; 2022 Feb; 12(3):. PubMed ID: 35330330
[TBL] [Abstract][Full Text] [Related]
19. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
[TBL] [Abstract][Full Text] [Related]
20. Opportunistic screening for familial hypercholesterolaemia via a community laboratory.
Bell DA; Hooper AJ; Bender R; McMahon J; Edwards G; van Bockxmeer FM; Watts GF; Burnett JR
Ann Clin Biochem; 2012 Nov; 49(Pt 6):534-7. PubMed ID: 23002132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
